Literature DB >> 28392144

Iridium-Knife: Another knife in radiation oncology.

Natasa Milickovic1, Nikolaos Tselis2, Efstratios Karagiannis3, Konstantinos Ferentinos3, Nikolaos Zamboglou3.   

Abstract

PURPOSE: Intratarget dose escalation with superior conformity is a defining feature of three-dimensional (3D) iridium-192 (192Ir) high-dose-rate (HDR) brachytherapy (BRT). In this study, we analyzed the dosimetric characteristics of interstitial 192Ir HDR BRT for intrathoracic and cerebral malignancies. We examined the dose gradient sharpness of HDR BRT compared with that of linear accelerator-based stereotactic radiosurgery and stereotactic body radiation therapy, usually called X-Knife, to demonstrate that it may as well be called a Knife. METHODS AND MATERIALS: Treatment plans for 10 patients with recurrent glioblastoma multiforme or intrathoracic malignancies, five of each entity, treated with X-Knife (stereotactic radiosurgery for glioblastoma multiforme and stereotactic body radiation therapy for intrathoracic malignancies) were replanned for simulated HDR BRT. For 3D BRT planning, we used identical structure sets and dose prescription as for the X-Knife planning. The indices for qualitative treatment plan analysis encompassed planning target volume coverage, conformity, dose falloff gradient, and the maximum dose-volume limits to different organs at risk.
RESULTS: Volume coverage in HDR plans was comparable to that calculated for X-Knife plans with no statistically significant difference in terms of conformity. The dose falloff gradient-sharpness-of the HDR plans was considerably steeper compared with the X-Knife plans.
CONCLUSIONS: Both 3D 192Ir HDR BRT and X-Knife are effective means for intratarget dose escalation with HDR BRT achieving at least equal conformity and a steeper dose falloff at the target volume margin. In this sense, it can reasonably be argued that 3D 192Ir HDR BRT deserves also to be called a Knife, namely Iridium-Knife.
Copyright © 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brachytherapy; High-dose-rate; Iridium-Knife; Stereotactic body radiation therapy; Stereotactic radiosurgery; X-Knife

Year:  2017        PMID: 28392144     DOI: 10.1016/j.brachy.2017.03.005

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  12 in total

1.  CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.

Authors:  Georgios Chatzikonstantinou; Nikolaos Zamboglou; Eleftherios Archavlis; Iosif Strouthos; Eleni Zoga; Natasha Milickovic; Basil Hilaris; Dimos Baltas; Claus Rödel; Nikolaos Tselis
Journal:  Strahlenther Onkol       Date:  2018-09-10       Impact factor: 3.621

2.  Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.

Authors:  Ranran Li; Ying Zhang; Yuan Yuan; Qi Lin; Jianjian Dai; Ruicai Xu; Xudong Hu; Mingyong Han
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

3.  Single fraction computed tomography-guided high-dose-rate brachytherapy or stereotactic body radiotherapy for primary and metastatic lung tumors?

Authors:  Mark Kh Chan; Venus Wy Lee; Noriyuki Kadoya; Chi-Leung Chiang; Matthew Yp Wong; Ronnie Wk Leung; Steven Cheung; Oliver Blanck
Journal:  J Contemp Brachytherapy       Date:  2018-10-31

4.  Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme.

Authors:  Georgios Chatzikonstantinou; Peter Ulrich; Eleftherios Archavlis; Nikolaos Zamboglou; Iosif Strouthos; Eleni Zoga; Dimos Baltas; Nikolaos Tselis
Journal:  J Contemp Brachytherapy       Date:  2019-06-28

5.  Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma.

Authors:  Franziska Walter; Lukas Nierer; Maya Rottler; Anna Sophie Duque; Helmut Weingandt; Justus Well; Roel Shpani; Guillaume Landry; Max Seidensticker; Florian Streitparth; Jens Ricke; Claus Belka; Stefanie Corradini
Journal:  Radiat Oncol       Date:  2021-05-06       Impact factor: 3.481

6.  Value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer.

Authors:  Keita Mamady; Xi Chen; Bah Malick; Zhaohui Fang; Huixian Niu; Traoré Bangaly; Hong Liu
Journal:  J Contemp Brachytherapy       Date:  2021-12-30

Review 7.  A Critical Overview of Targeted Therapies for Glioblastoma.

Authors:  Kewal K Jain
Journal:  Front Oncol       Date:  2018-10-15       Impact factor: 6.244

8.  The Preliminary Results of 3-Dimensional Printed Individual Template Assisted 192Ir High-Dose Rate Interstitial Brachytherapy for Central Recurrent Gynecologic Cancer.

Authors:  Ping Jiang; Ang Qu; Shuhua Wei; Haitao Sun; Xile Zhang; Xu Li; Junjie Wang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

9.  Deep learning-based digitization of prostate brachytherapy needles in ultrasound images.

Authors:  Christoffer Andersén; Tobias Rydén; Per Thunberg; Jakob H Lagerlöf
Journal:  Med Phys       Date:  2020-10-27       Impact factor: 4.071

Review 10.  The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry.

Authors:  Tibor Major; Georgina Fröhlich; Péter Ágoston; Csaba Polgár; Zoltán Takácsi-Nagy
Journal:  Strahlenther Onkol       Date:  2021-11-01       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.